Coronavirus Update: U.S. COVID-19 cases and hospitalizations continue to decline, but experts lament preventable deaths that have pushed toll above 700,000

This post was originally published on this site

U.S. cases and hospitalizations from the coronavirus-borne illness COVID-19 continued their recent steady decline on Monday, as the nation seems to be moving past a July surge caused by the highly transmissible delta variant.

There are currently about 20,000 fewer COVID-19 patients in hospitals across the U.S. as there were at the beginning of September, according to a New York Times tracker, and new cases are averaging 106,941 a day, down 28% from two weeks ago.

But the daily death toll remains close to 2,000 and the overall number of fatalities surpassed 700,000 late Friday. Experts lament that at least 200,000 of those were preventable as they came after vaccines became available, but many people living in the U.S. refused to get them.

The Centers for Disease Control and Prevention’s vaccine tracker is showing that 185.5 million people living in America are fully vaccinated, equal to about 56% of the population, a number that has remained relatively static for weeks.

Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases and President Joe Biden’s chief medical adviser, made yet another plea for unvaccinated people to get their shots over the weekend.

“I would hope that people would understand that all of this is for their benefit, for the safety of themselves, their family and their societal responsibility,” Fauci said on CNN’s “State of the Union,” as the Associated Press reported.

Fauci said he’s worried that people resisting COVID-19 vaccine shots based on religious grounds may be confusing that with a philosophical objection.

The COVID-19 vaccine is no different in concept from receiving other vaccines such as for measles, which have been done for many years, he said, adding that a public health review found “very, very few, literally less than a handful” of established religions which actually oppose vaccinations.

Religious exemptions have been on the rise since Biden last month announced sweeping new COVID-19 vaccine mandates covering more than 100 million Americans.

Don’t miss: How COVID-19 booster shots are good for business, and for the economy

At least three more airlines have joined United Airlines
UAL,
-0.36%

in requiring employees to be vaccinated against COVID-19, as the Biden administration steps up pressure on major U.S. carriers to require the shots, the AP reported separately.

American Airlines
AAL,
-1.11%
,
Alaska Airlines
ALK,
+0.10%

and JetBlue
JBLU,
-0.86%

will ask all employees to get their shots, as they provide special flights, cargo hauling and other services for the government. The companies say that makes them government contractors and thus covered by President Joe Biden’s order directing contractors to require that employees be vaccinated.

Your packages are getting a makeover. With retailers accelerating efforts to save money on packaging and delivery fees, WSJ’s Shelby Holliday reports on three ways your doorstep is looking different these days. Illustration: Sebastian Vega

American Airlines CEO Doug Parker told employees late Friday that the airline is still working on details, but “it is clear that team members who choose to remain unvaccinated will not be able to work at American Airlines.”

See also:The biggest risk facing investors this earnings season is lurking just beneath the surface

The head of BioNTech
BNTX,
-4.98%
,
the German partner to Pfizer
PFE,
-0.91%

in developing their COVID-19 vaccine, told the Financial Times that a different vaccine may be required by next year if the virus keeps mutating to the point it is resistant to vaccines and immune systems.

Chief executive officer Ugur Sahin expects the coming year’s focus on booster shots for the vaccinated and a continued effort to vaccinate the unvaccinated.

“We have no reason to assume that the next generation virus will be easier to handle for the immune system than the existing generation,” said Sahin in an interview.

Doctors are increasingly turning to monoclonal-antibody drugs to treat high-risk patients who get sick with Covid-19. WSJ takes a look at how the therapies work and why they’re important for saving lives. Illustration: Jacob Reynolds/WSJ

Elsewhere, New Zealand’s government acknowledged Monday what most other countries did long ago: It can no longer completely get rid of the coronavirus.

Prime Minister Jacinda Ardern announced a cautious plan to ease lockdown restrictions in Auckland, despite an outbreak there that continues to simmer.

World tourism surged in July, thanks to vaccination rollouts and fewer travel restrictions, but traveler numbers still fell far short of pre-pandemic levels, the UN’s tourism body said Monday, as AFP reported. Some 54 million tourists crossed international borders in July, the highest figure since April 2020, in the early months of the coronavirus crisis, the World Tourism Organization said in a statement. That was up 58% from last July.

There was more COVID-19 antiviral news following Merck’s
MRK,
+1.84%

announcement Friday that its experimental oral COVID-19 treatment helped keep people out of the hospital and from dying. Redhill Biopharma
RDHL,
+7.32%

said new data from a Phase 2/3 clinical study evaluating its experimental oral antiviral opaganib in severely ill, hospitalized COVID-19 patients found it reduced mortality by 62% when evaluating 251 of the 475 patients enrolled in the study.

See also:‘This is a profound game changer’: Merck’s antiviral pill cuts risk of COVID-19 hospitalization and death in half, data show

An FDA advisory committee will discuss the submissions made by Moderna
MRNA,
-6.11%

and Johnson & Johnson
JNJ,
-1.23%

seeking authorization for their COVID-19 vaccine boosters at a meeting scheduled for Oct. 14 and Oct. 15. 

Don’t miss:‘It’s not a magic pill’: What Merck’s antiviral pill could mean for vaccine hesitancy

Latest tallies

The global tally for the coronavirus-borne illness climbed above 235 million on Monday, while the death toll rose above 4.8 million, according to data aggregated by Johns Hopkins University.

The U.S. continues to lead the world with a total of 43.7 million cases and 701,92 deaths.

India is second by cases after the U.S. at 33.8 million and has suffered 448,997 deaths. Brazil has second highest death toll at 597,948 and 21.5 million cases.

In Europe, Russia has most fatalities at 207,056, followed by the U.K. at 137,338.

China, where the virus was first discovered late in 2019, has had 108,560 confirmed cases and 4,809 deaths, according to its official numbers, which are widely held to be massively underreported.

Add Comment